Molecular mechanisms underlying selective cytotoxic activity of BZL101, an extract of Scutellaria barbata, towards breast cancer cells

Cancer Biology and Therapy

Volumn 7, Issue 4, 2008, Pages 577-586

  Fong, Sylvia ^a   Shoemaker, Mark ^a   Cadaoas, Jaclyn ^a   Lo, Alvin ^a   Liao, Wayne ^b   Tagliaferri, Mary ^a   Cohen, Isaac ^a   Shtivelman, Emma ^a  

^a Bionovo Inc   (United States)

^b Phalanx Biotech Group   (United States)

Author keywords

BZL101; Glycolysis; PARP; ROS; Scutellaria barbata

Indexed keywords

BZL 101; NICOTINAMIDE ADENINE DINUCLEOTIDE; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PLANT EXTRACT; REACTIVE OXYGEN METABOLITE; SCUTELLARIA BARBATA EXTRACT;

ARTICLE; BREAST CANCER; CANCER CELL; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DRUG INHIBITION; GLYCOLYSIS; HUMAN; HUMAN CELL;

EID: 45349105163     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.7.4.5535     Document Type: Article

References (39)

1. Boon H, Wong J. Botanical medicine and cancer: a review of the safety and efficacy. Expert opinion on pharmacotherapy 2004; 5:2485-501.
2. Cragg GM, Newman DJ. Plants as a source of anti-cancer agents. Journal of ethnopharmacology 2005; 100:72-9.
3. Rugo H, Shtivelman E, Perez A, Vogel C, Franco S, Tan Chiu E, Melisko M, Tagliaferri M, Cohen I, Shoemaker M, Tran Z, Tripathy D. Phase I trial and antitumor effects of BZL101 for patients with advanced breast cancer. Breast Cancer Res Treat 2007; 105:17-28.
4. Campbell MJ, Hamilton B, Shoemaker M, Tagliaferri M, Cohen I, Tripathy D. Antiproliferative activity of Chinese medicinal herbs on breast cancer cells in vitro. Anticancer Res 2002; 22:3843-52.
5. Shoemaker M, Hamilton B, Dairkee SH, Cohen I, Campbell MJ. In vitro anticancer activity of twelve Chinese medicinal herbs. Phytother Res 2005; 19:649-51.
6. Gatenby RA, Gillies RJ. Why do cancers have high aerobic glycolysis? Nature reviews 2004; 4:891-9.
7. Hayes JD, McMahon M. Molecular basis for the contribution of the antioxidant responsive element to cancer chemoprevention. Cancer letters 2001; 174:103-13.
8. Struthers L, Patel R, Clark J, Thomas S. Direct detection of 8-oxodeoxyguanosine and 8-oxoguanine by avidin and its analogues. Analytical biochemistry 1998; 255:20-31.
9. Kim MY, Zhang T, Kraus WL. Poly(ADP-ribosyl)ation by PARP-1: 'PAR-laying' NAD+ into a nuclear signal. Genes & development 2005; 19:1951-67.
10. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB. Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes & development 2004; 18:1272-82.
11. Burkle A. Poly(ADP-ribose). The most elaborate metabolite of NAD+. Febs J 2005; 272:4576-89.
12. Ying W, Alano CC, Garnier P, Swanson RA. NAD+ as a metabolic link between DNA damage and cell death. J Neurosci Res 2005; 79:216-23.
13. Eguchi Y, Shimizu S, Tsujimoto Y. Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer research 1997; 57:1835-40.
14. Leist M, Single B, Castoldi AF, Kuhnle S, Nicotera P. Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. The Journal of experimental medicine 1997; 185:1481-6.
15. Bradbury DA, Simmons TD, Slater KJ, Crouch SP. Measurement of the ADP:ATP ratio in human leukaemic cell lines can be used as an indicator of cell viability, necrosis and apoptosis. Journal of immunological methods 2000; 240:79-92.
16. Mukhopadhyay SS, Leung KS, Hicks MJ, Hastings PJ, Youssoufian H, Plon SE. Defective mitochondrial peroxiredoxin-3 results in sensitivity to oxidative stress in Fanconi anemia. J Cell Biol 2006; 175:225-35.
17. Storz P, Doppler H, Ferran C, Grey ST, Toker A. Functional dichotomy of A20 in apoptotic and necrotic cell death. The Biochemical Journal 2005; 387:47-55.
18. Kang Y, Chen CR, Massague J. A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. Molecular Cell 2003; 11:915-26.
19. Perk J, Iavarone A, Benezra R. Id family of helix-loop-helix proteins in cancer. Nature Reviews 2005; 5:603-14.
20. Szatrowski TP, Nathan CF. Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Research 1991; 51:794-8.
21. Brandon M, Baldi P, Wallace DC. Mitochondrial mutations in cancer. Oncogene 2006; 25:4647-62.
22. Behrend L, Henderson G, Zwacka RM. Reactive oxygen species in oncogenic transformation. Biochemical Society Transactions 2003; 31:1441-4.
23. Martindale JL, Holbrook NJ. Cellular response to oxidative stress: signaling for suicide and survival. Journal of Cellular Physiology 2002; 192:1-15.
24. Trachootham D, Zhou Y, Zhang H, Demizu Y, Chen Z, Pelicano H, Chiao PJ, Achanta G, Arlinghaus RB, Liu J, Huang P. Selective killing of oncogenically transformed cells through a ROS-mediated mechanism by beta-phenylethyl isothiocyanate. Cancer Cell 2006; 10:241-52.
25. Lambeth JD. NOX enzymes and the biology of reactive oxygen. Nat Rev Immunol 2004; 4:181-9.
26. Szabo C, Dawson VL. Role of poly(ADP-ribose) synthetase in inflammation and ischaemiareperfusion. Trends in Pharmacological Sciences 1998; 19:287-98.
27. Yu SW, Wang H, Poitras MF, Coombs C, Bowers WJ, Federoff HJ, Poirier GG, Dawson TM, Dawson VL. Mediation of poly(ADP-ribose) polymerase-1-dependent cell death by apoptosis-inducing factor. Science (New York, NY) 2002; 297:259-63.
28. Kobayashi K, Neely JR. Control of maximum rates of glycolysis in rat cardiac muscle. Circulation Research 1979; 44:166-75.
29. Mendoza-Alvarez H, Alvarez-Gonzalez R. Regulation of p53 sequence-specific DNA-binding by covalent poly(ADP-ribosyl)ation. The Journal of Biological Chemistry 2001; 276:36425-30.
30. Valenzuela MT, Guerrero R, Nunez MI, Ruiz De Almodovar JM, Sarker M, de Murcia G, Oliver FJ. PARP-1 modifies the effectiveness of p53-mediated DNA damage response. Oncogene 2002; 21:1108-16.
31. Oliver FJ, Menissier-de Murcia J, Nacci C, Decker P, Andriantsitohaina R, Muller S, de la Rubia G, Stoclet JC, de Murcia G. Resistance to endotoxic shock as a consequence of defective NFkappaB activation in poly (ADP-ribose) polymerase-1 deficient mice. The EMBO Journal 1999; 18:4446-54.
32. Chan JY, Tang PM, Hon PM, Au SW, Tsui SK, Waye MM, Kong SK, Mak TC, Fung KP. Pheophorbide a, a major antitumor component purified from Scutellaria barbata, induces apoptosis in human hepatocellular carcinoma cells. Planta Medica 2006; 72:28-33.
33. Dai SJ, Chen M, Liu K, Jiang YT, Shen L. Four New neo-Clerodane Diterpenoid Alkaloids from Scutellaria barbata with Cytotoxic Activities. Chemical & Pharmaceutical Bulletin 2006; 54:869-72.
34. Dai SJ, Wang GF, Chen M, Liu K, Shen L. Five new neo-clerodane diterpenoid alkaloids from Scutellaria barbata with cytotoxic activities. Chemical & Pharmaceutical Bulletin 2007; 55:1218-21.
35. Ducki S, Hadfield JA, Lawrence NJ, Liu CY, McGown AT, Zhang X. Isolation of E-1-(4′-Hydroxyphenyl)-but-1-en-3-one from Scutellaria barbata. Planta Medica 1996; 62:185-6.
36. Sato Y, Suzaki S, Nishikawa T, Kihara M, Shibata H, Higuti T. Phytochemical flavones isolated from Scutellaria barbata and antibacterial activity against methicillin-resistant Staphylococcus aureus. Journal of Ethnopharmacology 2000; 72:483-8.
37. Wang WS, Zhou YW, Ye YH, Du N. [Studies on the flavonoids in herb from Scutellaria barbata]. China Journal of Chinese Materia Medica 2004; 29:957-9.
38. Chui CH, Lau FY, Tang JC, Kan KL, Cheng GY, Wong RS, Kok SH, Lai PB, Ho R, Gambari R, Chan AS. Activities of fresh juice of Scutellaria barbata and warmed water extract of Radix Sophorae Tonkinensis on anti-proliferation and apoptosis of human cancer cell lines. International Journal of Molecular Medicine 2005; 16:337-41.
39. Goh D, Lee YH, Ong ES. Inhibitory effects of a chemically standardized extract from Scutellaria barbata in human colon cancer cell lines, LoVo. Journal of Agricultural and Food Chemistry 2005; 53:8197-204.